Zelira Therapeutics, created in 2000 (Australia), from 2214 competing brands. Zelira Therapeutics is a brand of Zelira Therapeutics Ltd, listed on the stock exchange of Francfort. The International Securities Identification Number (ISIN) of Zelira Therapeutics Ltd is AU000000ZLD1. Zelira Therapeutics belongs to the Biotechnology business sector.

Zelira Therapeutics is a brand of Zelira Therapeutics Ltd (G1G) Share price

Date created : 2000 Business sector Biotechnology

Share price and profitability of the share Zelira Therapeutics Ltd (Zelira Therapeutics)

Buy Zelira Therapeutics Ltd share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 0.41

Portfolio valuation
Zelira Therapeutics Ltd (Zelira Therapeutics) over 5 years* EUR 5.71

Stock market history Zelira Therapeutics Ltd (Zelira Therapeutics)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Zelira Therapeutics Ltd

See more brands of Zelira Therapeutics Ltd

Rival brands
Zelira Therapeutics

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS